Survey among experts on the future role of tau‐PET in clinical practice and trials
Abstract BACKGROUND Recent advancements in Alzheimer's disease (AD) biomarker research and clinical trials prompt reflection on the value and consequently appropriate use of tau positron emission tomography (tau‐PET) in the future. METHODS We conducted an online survey among dementia and PET ex...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-10-01
|
| Series: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/dad2.70033 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850240211266568192 |
|---|---|
| author | Marie R. Vermeiren Ismael L. Calandri Wiesje M. van derFlier Elsmarieke van deGiessen Rik Ossenkoppele |
| author_facet | Marie R. Vermeiren Ismael L. Calandri Wiesje M. van derFlier Elsmarieke van deGiessen Rik Ossenkoppele |
| author_sort | Marie R. Vermeiren |
| collection | DOAJ |
| description | Abstract BACKGROUND Recent advancements in Alzheimer's disease (AD) biomarker research and clinical trials prompt reflection on the value and consequently appropriate use of tau positron emission tomography (tau‐PET) in the future. METHODS We conducted an online survey among dementia and PET experts worldwide to investigate the anticipated future role of tau‐PET in clinical practice and trials. RESULTS Two hundred sixty‐eight dementia experts, comprising 143 clinicians and 121 researchers, covering six continents participated. The vast majority (90%) fostered a positive attitude toward the added value of tau‐PET in clinical practice, particularly for staging, diagnosing, monitoring, and prognostication in a cognitively impaired memory clinic population. Experts anticipated an important role for tau‐PET for participant selection (76%–100%) and measuring endpoints (75%–97%), in both anti‐amyloid and anti‐tau drug trials. DISCUSSION Our global survey study shows that dementia experts envision an important role for tau‐PET in the future, both in clinical practice and in drug trials, beyond current guidelines and practices. Highlights Dementia experts envision an important role for tau‐PET in the future. Experts indicate that a tau‐PET scan could influence patient management. Experts anticipate the utility of tau‐PET for participant selection and endpoints in drug trials. There is a gap between the anticipated usefulness of tau‐PET and current clinical practices. |
| format | Article |
| id | doaj-art-4d4967d1b7cd47a5851d1892366de602 |
| institution | OA Journals |
| issn | 2352-8729 |
| language | English |
| publishDate | 2024-10-01 |
| publisher | Wiley |
| record_format | Article |
| series | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
| spelling | doaj-art-4d4967d1b7cd47a5851d1892366de6022025-08-20T02:00:55ZengWileyAlzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring2352-87292024-10-01164n/an/a10.1002/dad2.70033Survey among experts on the future role of tau‐PET in clinical practice and trialsMarie R. Vermeiren0Ismael L. Calandri1Wiesje M. van derFlier2Elsmarieke van deGiessen3Rik Ossenkoppele4Alzheimer Center Amsterdam, Neurology Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam The NetherlandsAlzheimer Center Amsterdam, Neurology Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam The NetherlandsAlzheimer Center Amsterdam, Neurology Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam The NetherlandsRadiology & Nuclear Medicine Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam The NetherlandsAlzheimer Center Amsterdam, Neurology Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam The NetherlandsAbstract BACKGROUND Recent advancements in Alzheimer's disease (AD) biomarker research and clinical trials prompt reflection on the value and consequently appropriate use of tau positron emission tomography (tau‐PET) in the future. METHODS We conducted an online survey among dementia and PET experts worldwide to investigate the anticipated future role of tau‐PET in clinical practice and trials. RESULTS Two hundred sixty‐eight dementia experts, comprising 143 clinicians and 121 researchers, covering six continents participated. The vast majority (90%) fostered a positive attitude toward the added value of tau‐PET in clinical practice, particularly for staging, diagnosing, monitoring, and prognostication in a cognitively impaired memory clinic population. Experts anticipated an important role for tau‐PET for participant selection (76%–100%) and measuring endpoints (75%–97%), in both anti‐amyloid and anti‐tau drug trials. DISCUSSION Our global survey study shows that dementia experts envision an important role for tau‐PET in the future, both in clinical practice and in drug trials, beyond current guidelines and practices. Highlights Dementia experts envision an important role for tau‐PET in the future. Experts indicate that a tau‐PET scan could influence patient management. Experts anticipate the utility of tau‐PET for participant selection and endpoints in drug trials. There is a gap between the anticipated usefulness of tau‐PET and current clinical practices.https://doi.org/10.1002/dad2.70033Alzheimer's diseasepositron emission tomographytautrials |
| spellingShingle | Marie R. Vermeiren Ismael L. Calandri Wiesje M. van derFlier Elsmarieke van deGiessen Rik Ossenkoppele Survey among experts on the future role of tau‐PET in clinical practice and trials Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring Alzheimer's disease positron emission tomography tau trials |
| title | Survey among experts on the future role of tau‐PET in clinical practice and trials |
| title_full | Survey among experts on the future role of tau‐PET in clinical practice and trials |
| title_fullStr | Survey among experts on the future role of tau‐PET in clinical practice and trials |
| title_full_unstemmed | Survey among experts on the future role of tau‐PET in clinical practice and trials |
| title_short | Survey among experts on the future role of tau‐PET in clinical practice and trials |
| title_sort | survey among experts on the future role of tau pet in clinical practice and trials |
| topic | Alzheimer's disease positron emission tomography tau trials |
| url | https://doi.org/10.1002/dad2.70033 |
| work_keys_str_mv | AT mariervermeiren surveyamongexpertsonthefutureroleoftaupetinclinicalpracticeandtrials AT ismaellcalandri surveyamongexpertsonthefutureroleoftaupetinclinicalpracticeandtrials AT wiesjemvanderflier surveyamongexpertsonthefutureroleoftaupetinclinicalpracticeandtrials AT elsmariekevandegiessen surveyamongexpertsonthefutureroleoftaupetinclinicalpracticeandtrials AT rikossenkoppele surveyamongexpertsonthefutureroleoftaupetinclinicalpracticeandtrials |